C
PLRX icon

Covestor’s Pliant Therapeutics PLRX Stock Holding History

Covestor’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45
Closed – – 2661
2025
Q4 		$0 Sell
45
-1
-2% -$2 ﹤0.01% 2633
2025
Q3 		$0 Hold
46
– – ﹤0.01% 2650
2025
Q2 		$0 Buy
46
+40
+667% +$57 ﹤0.01% 2629
2025
Q1 		$0 Hold
6
– – ﹤0.01% 2607
2024
Q4 		$0 Buy
6
+1
+20% +$14 ﹤0.01% 2617
2024
Q3 		$0 Sell
5
-1
-17% -$13 ﹤0.01% 2625
2024
Q2 		$0 Hold
6
– – ﹤0.01% 2629
2024
Q1 		$0 Hold
6
– – ﹤0.01% 2617
2023
Q4 		$0 Sell
6
-1
-14% -$15 ﹤0.01% 2577
2023
Q3 		$0 Buy
+7
New +$121 ﹤0.01% 2567

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Covestor's PLRX Position: Q1 2026 in Review

Covestor sold out of Pliant Therapeutics (PLRX) in Q1 2026, closing a stake of 45 shares.

Covestor first reported a position in PLRX in Q3 2023 and held it in 10 quarters. The position peaked at $0 in Q4 2025. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Covestor reported no remaining Pliant Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Covestor sold 45 Pliant Therapeutics shares in Q1 2026.
  • Covestor first reported a position in Pliant Therapeutics in Q3 2023 and held it in 10 quarters.
  • Covestor's Pliant Therapeutics position peaked at $0 in Q4 2025.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.